Paydirt
JK
Insider

James Kihara

PRINCIPAL ACCOUNTING OFFICER

James Kihara (PRINCIPAL ACCOUNTING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $298K of ACAD (11,421 sh × $26.08, as filed), executed Jun 26.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$412K
shares × price, as filed
Last traded
Jun 26
Filed Jun 29

Median ADV $49.5M across their filed names

Open performance
Volume by month
$298K$149K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · sells $114KJun 2026 · sells $298K
Buys $0 Sells $412K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
ACAD ACADIA Pharmaceuticals Inc. ACAD · 0 buys · 2 sells 2 filings
Recent filings
ACADSALE ACADIA Pharmaceuticals Inc. View filing → $298K
11,421 sh × $26.08
Exec Jun 26
Filed Jun 29 · 5:30 PM ET
ACADSALE ACADIA Pharmaceuticals Inc. View filing → $114K
5,401 sh × $21.18
Exec May 26
Filed May 27 · 5:30 PM ET